Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
8.54
+0.54 (6.75%)
At close: Jun 12, 2026, 4:00 PM EDT
8.61
+0.07 (0.82%)
Pre-market: Jun 15, 2026, 7:39 AM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $414.94 million as of June 15, 2026. Its market cap has increased by 730.81% in one year.
Market Cap
414.94M
Enterprise Value
338.42M
1-Year Change
730.81%
Ranking
Category
Stock Price
$8.54
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has increased from $176.76M to $414.94M, an increase of 134.75%. That is a compound annual growth rate of 56.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 414.94M | 294.07% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 429.27M |
| Forte Biosciences | 429.09M |
| Rezolute | 417.87M |
| Autolus Therapeutics | 415.18M |
| Adlai Nortye | 412.80M |
| Ocugen | 409.61M |
| vTv Therapeutics | 406.60M |
| Century Therapeutics | 405.80M |